ArticleBMC public health2025
Association of cardiovascular health with morbidity and mortality among U.S. adults with osteoarthritis: a population-based study.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of life's essential 8 and genetic predisposition with the risk of osteoarthritis: a prospective cohort study.Frontiers in nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundOsteoarthritis (OA) is recognized as the most common joint disease with serious public health implications. Cardiovascular health (CVH) is also an issue that is frequently emphasized in public health and has an impact on a variety of diseases and mortality rates. This study aims to investigate the association of CVH with the morbidity of OA. And explore the association of CVH with both all-cause and cardiovascular disease (CVD) mortality among US adults with OA.
methodsThis study utilized data from the National Health and Nutrition Examination Survey 2005-2018, which included 21,289 adults aged ≥ 20, representing 137,912,968 Americans. CVH was assessed by Life's Essential 8 (LE8) includes 4 behavior and 4 factor metrics. Total LE8 scores were calculated from the unweighted average on a 0-100 scale and were categorized as high (80-100), moderate (50-79), and low (0-49) CVH. Multivariable logistic regression explored the association of OA with CVH. Cox proportional hazards regression examined LE8 associations with mortality.
resultsAdjusting for confounding variables, per 10 points LE8 increase, the OR was 0.82 in association with OA, while OA morbidity were decreased by 30% (OR 0.70, 95%CI 0.57, 0.87) and 54% (OR 0.46, 95%CI 0.36, 0.60) in moderate and high CVH compared to low CVH. During a median follow-up of 7.58 years in OA participants, per 10 points LE8 increase were decreased 23% mortality of all-cause (HR 0.77, 95%CI 0.70, 0.85) and 29% mortality of CVD (HR 0.71, 95% 0.60, 0.84). Moderate and high CVH demonstrated a decreased mortality of both all-cause and CVD compared with low CVH.
conclusionsHigher CVH is associated with a lower morbidity of OA and lower mortality in OA participants. Our results suggest that adherence to CVH could reduce the morbidity of OA and improve survival outcomes for those affected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.